Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

98 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
MicroRNAs: tools for cancer diagnostics.
Paranjape T, Slack FJ, Weidhaas JB. Paranjape T, et al. Among authors: weidhaas jb. Gut. 2009 Nov;58(11):1546-54. doi: 10.1136/gut.2009.179531. Gut. 2009. PMID: 19834118 Free PMC article.
MicroRNAs as potential cancer therapeutics.
Trang P, Weidhaas JB, Slack FJ. Trang P, et al. Among authors: weidhaas jb. Oncogene. 2008 Dec;27 Suppl 2(Suppl 2):S52-7. doi: 10.1038/onc.2009.353. Oncogene. 2008. PMID: 19956180 Free PMC article. Review.
Regression of murine lung tumors by the let-7 microRNA.
Trang P, Medina PP, Wiggins JF, Ruffino L, Kelnar K, Omotola M, Homer R, Brown D, Bader AG, Weidhaas JB, Slack FJ. Trang P, et al. Among authors: weidhaas jb. Oncogene. 2010 Mar 18;29(11):1580-7. doi: 10.1038/onc.2009.445. Epub 2009 Dec 7. Oncogene. 2010. PMID: 19966857 Free PMC article.
A Variant in a MicroRNA complementary site in the 3' UTR of the KIT oncogene increases risk of acral melanoma.
Godshalk SE, Paranjape T, Nallur S, Speed W, Chan E, Molinaro AM, Bacchiocchi A, Hoyt K, Tworkoski K, Stern DF, Sznol M, Ariyan S, Lazova R, Halaban R, Kidd KK, Weidhaas JB, Slack FJ. Godshalk SE, et al. Among authors: weidhaas jb. Oncogene. 2011 Mar 31;30(13):1542-50. doi: 10.1038/onc.2010.536. Epub 2010 Nov 29. Oncogene. 2011. PMID: 21119596 Free PMC article.
A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer.
Ratner ES, Keane FK, Lindner R, Tassi RA, Paranjape T, Glasgow M, Nallur S, Deng Y, Lu L, Steele L, Sand S, Muller RU, Bignotti E, Bellone S, Boeke M, Yao X, Pecorelli S, Ravaggi A, Katsaros D, Zelterman D, Cristea MC, Yu H, Rutherford TJ, Weitzel JN, Neuhausen SL, Schwartz PE, Slack FJ, Santin AD, Weidhaas JB. Ratner ES, et al. Among authors: weidhaas jb. Oncogene. 2012 Oct 18;31(42):4559-66. doi: 10.1038/onc.2011.539. Epub 2011 Dec 5. Oncogene. 2012. PMID: 22139083 Free PMC article.
MicroRNAs as a potential magic bullet in cancer.
Slack FJ, Weidhaas JB. Slack FJ, et al. Among authors: weidhaas jb. Future Oncol. 2006 Feb;2(1):73-82. doi: 10.2217/14796694.2.1.73. Future Oncol. 2006. PMID: 16556074 Review.
98 results